Sung K. Kim

St. Vincent's Hospital
Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Blood viscosity is associated with smoking status rather than the presence of chronic obstructive pulmonary disease: findings from the Korea COPD Subgroup Study (KOCOSS).

Blood viscosity is associated with smoking status rather than the presence of chronic obstructive pulmonary disease: findings from the Korea COPD Subgroup Study (KOCOSS).

Journal: Respiratory research

Published: March 17, 2026

Integrative analysis of in silico predictions and clinical evidence to delineate the capability of HiFi long-read sequencing in paralogous genes.

Integrative analysis of in silico predictions and clinical evidence to delineate the capability of HiFi long-read sequencing in paralogous genes.

Journal: NPJ genomic medicine

Published: November 07, 2025

Effects of Peer-Delivered Practice Intervention with Fostering Walking Leaders for Participation in Healthy Walking Activities and Awareness of the Community Walking Environment.

Effects of Peer-Delivered Practice Intervention with Fostering Walking Leaders for Participation in Healthy Walking Activities and Awareness of the Community Walking Environment.

Journal: Journal of lifestyle medicine

Published: July 07, 2025

Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements.

Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements.

Journal: Therapeutic advances in medical oncology

Published: October 27, 2024

Baseline lung function and risk of incident tuberculosis: a nationwide population-based cohort study.

Baseline lung function and risk of incident tuberculosis: a nationwide population-based cohort study.

Journal: PloS one

Published: April 25, 2024

Real-world study of lazertinib as second-line or greater treatment in advanced non-small cell lung cancer.

Real-world study of lazertinib as second-line or greater treatment in advanced non-small cell lung cancer.

Journal: Thoracic cancer

Published: March 13, 2024

Low pre-immunotherapy forced vital capacity is associated with poor outcomes in non-small cell lung cancer patients receiving immunotherapy regardless of prior treatment history.

Low pre-immunotherapy forced vital capacity is associated with poor outcomes in non-small cell lung cancer patients receiving immunotherapy regardless of prior treatment history.

Journal: Therapeutic advances in medical oncology

Published: February 12, 2024

Endobronchial valves for emphysema and persistent air-leak: 10-year experience in an Asian country.

Endobronchial valves for emphysema and persistent air-leak: 10-year experience in an Asian country.

Journal: BMC pulmonary medicine

Published: December 12, 2023

Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis.

Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis.

Journal: Respirology (Carlton, Vic.)

Published: July 06, 2023

Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy.

Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy.

Journal: Thoracic cancer

Published: June 30, 2023

Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea.

Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea.

Journal: Open forum infectious diseases

Published: May 17, 2023

Smoking Status at Time of Diagnosis Affects the Efficacy of Anti-PD-1/L1 Therapy in Patients With Advanced NSCLC.

Smoking Status at Time of Diagnosis Affects the Efficacy of Anti-PD-1/L1 Therapy in Patients With Advanced NSCLC.

Journal: In vivo (Athens, Greece)

Published: May 13, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026